Category: COVID-19

“Vaccine Diplomacy” ~ U.S. Stopped Approval of Russia’s Vaccine to Brazil; Now Brazilian Deaths Rising

U.S. Dept. of Health and Human Services Brags It Used Diplomatic Pressure To Stop Brazil from Approving Russia’s COVID Vaccine March 16, 2021 (EIRNS) — The annual report of the HHS’s Office of Global Affairs stated that they had “used diplomatic relations in the Americas region” to stop Russian and Chinese “vaccine diplomacy” in the […]

Read More

COVID-19: Brazilian Infections Critical Point; Lula de Silva says were avoidable

Lula Calls Bolsonaro an “Imbecile” for His Handling of the COVID Crisis March 11, 2021 (EIRNS) – Brazilian former President Lula de Silva yesterday delivered his first public speech since his phony conviction for graft was overturned by the Brazilian Supreme Court earlier this week, and he used the occasion to rip into President Jair […]

Read More

Growing U.S. Acceptance of Vaccine Usage

Vaccination Is Increasing Americans’ Acceptance of Vaccines March 7 (EIRNS) – A number of new polls appear to show a continuing increase in acceptance of COVID-19 vaccination as the vaccines are actually available and their distribution has reached tens of millions of people without ill effects, The Hill reported March 4. There was a point […]

Read More

COVID-19: Vaccine Access for All

China Announces Plans To Produce 3.5 Billion Vaccine Doses in 2021 March 4, 2021 (EIRNS)–A major expansion of COVID-19 vaccine production is underway in China, now surpassing 3.5 billion doses in 2021. Further, China has decided to vaccinate 560 million of its citizens by June 30, an average of about five million/day. The U.S. is […]

Read More

COVID-19: new tool in the arsenal to defeat it.

Johnson & Johnson One-Dose COVID-19 Vaccine Passes FDA Advisory Board Unanimously Feb. 27 (EIRNS)—The U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC) passed the Johnson & Johnson one-dose vaccine unanimously on Feb. 26, the company announced in a press release today. The vaccine has a 72% efficacy in the U.S. and 64% […]

Read More